scholarly journals Is thyroid excision mandatory with laryngectomy in carcinoma larynx?

BMC Cancer ◽  
2020 ◽  
Vol 20 (1) ◽  
Author(s):  
Surendra Singh Baghel ◽  
Pawan Singhal ◽  
Namita Verma ◽  
Ritu Sehra ◽  
Rajeev Yadav ◽  
...  
Keyword(s):  
1999 ◽  
Vol 113 (5) ◽  
pp. 433-438 ◽  
Author(s):  
A. Thakar ◽  
S. Bahadur ◽  
D. A. Tandon ◽  
A. Ranganathan ◽  
G. K. Rath

AbstractTotal laryngectomy for advanced carcinoma of the larynx is effective but functionally disabling. In an effort at laryngeal preservation, 33 patients of stage III/IV carcinoma larynx were treated between 1987 and 1991 with induction chemotherapy followed by definitive radiation. Two chemotherapy protocols were administered. Group I patients received one to three cycles of cisplatin 100 mg/m2 (day 1), bleomycin 15 U/m2 (day 1), and 5-fluorouracil 1000 mg/m2/day (day 2 to 5) at three weekly intervals. This was then followed by radiotherapy. Group II received one to six weekly injections of single agent methotrexate 50 mg/m2 with or without leucocovorin rescue followed by radiotherapy. Any recurrence was salvaged by surgery.Midway through the study, Group II protocol was discontinued as the initial results were not comparable with Group I or standard treatment. The Group I protocol, however, yielded an initial locoregional control rate of 83.3 per cent With the addition of surgical salvage the locoregional control rate was 94.4 per cent and the control rate with laryngeal preservation was 88.8 per cent. The Kaplan-Meier probability of two years and five years disease-free survival was 81.9 per cent and 61.4 per cent respectively. For disease-free survival with laryngeal preservation the corresponding figures for two years and five years were 58.3 per cent and 41.7 per cent.The control group of 51 patients treated with radical surgery followed by radiotherapy yielded survival figures at two years and five years of 64.3 per cent and 57.2 per cent. The difference in the survival of Group I and the control group was not statistically significant (p value = 0.280). These initial results indicate that for stage III and for surgically resectable stage IV laryngeal carcinomas, a protocol of induction combination chemotherapy consisting of cisplatin, bleomycin and 5-fluorouracil followed by radiotherapy and combined with surgical salvage whenever required, can lead to comparable cure rates. In addition, a large proportion of patients are spared the morbidity of a total laryngectomy.


1995 ◽  
Vol 47 (3) ◽  
pp. 190-195
Author(s):  
G. K. Shukla ◽  
H. Sharma ◽  
S. C. Mishra ◽  
N. Bhatia ◽  
A. Agarawal
Keyword(s):  

1968 ◽  
Vol 20 (4) ◽  
pp. 178-184
Author(s):  
B. K. Roy Chaudhuri ◽  
A. Sinha ◽  
B. M. Abrol

1990 ◽  
Vol 42 (2) ◽  
pp. 50-53
Author(s):  
Ashok Yerma ◽  
Satish Mehta ◽  
Naresh K. Panda ◽  
S. B. S. Mann ◽  
Y. N. Mehra
Keyword(s):  

Author(s):  
Major Mirza Baig
Keyword(s):  

Author(s):  
AK Tyagi ◽  
D Rautray
Keyword(s):  

2014 ◽  
Vol 26 (1) ◽  
pp. 41-45
Author(s):  
Md Mostafizur Rahman ◽  
Belayat Hossain Siddiquee ◽  
Md Afzal Karim ◽  
Tawfiqur Rahman ◽  
Fatema Nihar ◽  
...  

The study was undertaken to compare between surgery and radiotherapy in early carcinoma larynx (T1N0). 60 cases of early carcinoma larynx were selected purposive sampling technique from all the patients of carcinoma larynx admitted into Otolaryngology and Head-Neck Surgery Department of Bangabandhu Sheikh Mujib Medical University,Dhaka; Dhaka Medical College Hospital,Dhaka; Shaheed Suhrawardy Medical College Hospital, Dhaka; Taqwah Specialized Hospital,Dhaka from January 2010 to June 2011. Carcinoma of the larynx is the most common cancer affecting the head and neck region. The main aim of this study was to determine whether there was any difference in the two main therapeutic options. The secondary aim was to assess speech and voice quality in a small, randomized sample of patients from each treatment group. The subjects investigated were 60 patients with T1N0 squamous cell carcinoma of the larynx. 30 patients were treated by irradiation, and 30 were treated with surgery. The primary outcome measures were recurrence at the primary site, recurrence in the neck. The secondary outcome measure was speech and voice quality. Surgery included laser assisted partial laryngectomy and various minor procedures on the glottis, including cordectomy. Surgery was more likely to be carried out for supraglottic disease. Result showed 16.67% of the irradiation group had a primary site recurrence compared with 20.0% in the surgery group at 12th months (p = 0.59) and 6.67% of those who were treated with irradiation had a recurrence in the neck. 16.67% of patients in the surgery group had a recurrence in the neck (p < 0.05). There was no significant difference in primary site recurrence rates for the two treatment modalities, but regional recurrence was higher in the surgery group. Regarding speech and voice quality, radiotherapy was far superior to surgery. All patients in the radiotherapy group but only 3 of 10 in the surgery group were judged to have a good or normal voice (p = .0017). Both surgery and irradiation are equally effective at treating early laryngeal carcinoma but Speech and voice quality were significantly better in patients treated by irradiation than those treated by surgery. DOI: http://dx.doi.org/10.3329/medtoday.v26i1.21312 Medicine Today 2014 Vol.26(1): 41-45


Sign in / Sign up

Export Citation Format

Share Document